Voceryq Submitted for EU Approval to Treat RRP
Inovio's Voceryq already received accelerated approval granted by the FDA to treat adults with recurrent respiratory papillomatosis.
Inovio's Voceryq already received accelerated approval granted by the FDA to treat adults with recurrent respiratory papillomatosis.
A recent cruise ship outbreak of the Andes strain underscores the potential for silent spread and severe respiratory complications in travel networks.
GE's Critical Care Suite 3.0 adds pediatric capabilities and provides bedside feeding tube placement detection without requiring cloud connectivity.
Young children treated with dupilumab (Dupixent) for eosinophilic esophagitis (EoE) were less likely to develop asthma later.